Jenny Kobin | executive |
George Lasezkay | executive |
Charlie Deignan | executive |
Jonathan Wolleben | analyst |
Caroline Kimberly Pocher | analyst |
Sean Kim | analyst |
Rohit Bhasin | analyst |
Jack Padovano | analyst |
Yi Chen | analyst |
Greetings, and welcome to the Clearside Biomedical Second Quarter 2023 Financial Results and Corporate Update Call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Jenny Kobin, of Investor Relations.
You may begin.
Good afternoon, everyone, and thank you for joining us on the call today.